Thermo Fisher Scientific, Inc. has acquired Sterilin, Ltd., a provider of single-use plastic products for the microbiology, life sciences and clinical markets. Sterilin, headquartered in South Wales, U.K., has 270 employees and had approximately $35 million in revenues in 2010.
“This acquisition broadens the range of innovative specialty laboratory products we can offer our customers,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. “It is also consistent with our strategy to leverage our global sales and support organization to give our customers across Europe, Asia-Pacific and North America greater access to these products.”
Sterilin’s portfolio includes quality disposable plastic products used in sample collection, preservation and processing, including a line of tissue culture plastics. The business will be integrated into Thermo Fisher’s Laboratory Products and Services Segment.